Your session is about to expire
← Back to Search
Behavioral Intervention
Yoga Program for Prostate Cancer
N/A
Waitlist Available
Led By Abigail Silva, PhD MPH BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled to undergo robotic-assisted or open radical prostatectomy
Patients must be age 18 year or older
Must not have
Patients currently participating in yoga practice (twice weekly in past three months) and have any of the following conditions: neurogenic bladder, (uncontrolled/major) cardiac arrhythmia, psychosis, cognitive impairment
Unable to participate in low- to moderate-intensity physical activity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in level of depression from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess if yoga can improve side effects from prostate cancer treatment, like ED and UI, and help cancer survivors manage their treatment side effects.
Who is the study for?
This trial is for men over 18 with localized prostate cancer who are about to have surgery. They must speak English, be able to attend yoga sessions in person and online, and not currently practice yoga regularly. Men with certain medical conditions or substance abuse issues cannot join.
What is being tested?
The study tests a hybrid yoga program designed to help manage side effects from prostate cancer surgery, like erectile dysfunction and urinary incontinence. Participants will do yoga twice weekly before and after their surgery, both virtually and in-person.
What are the potential side effects?
Yoga is generally safe but may include mild discomfort or muscle strain. Since it's low- to moderate-intensity exercise, risks are minimal compared to drug treatments; however, individuals should consider their physical limitations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a major prostate surgery using a robot or traditional method.
Select...
I am 18 years old or older.
Select...
My prostate cancer diagnosis was confirmed with a biopsy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I practice yoga twice a week and have a condition like neurogenic bladder, severe heart rhythm problems, psychosis, or cognitive issues.
Select...
I cannot do light to moderate exercise.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in level of depression from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in level of depression from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in level of erectile dysfunction from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Change in level of urinary incontinence from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Secondary study objectives
Change in level of anxiety from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Change in level of cancer-related fatigue from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
Change in level of quality of life from baseline to 4-weeks of pre-habilitation yoga and to 8-weeks of rehabilitation yoga
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: YogaExperimental Treatment2 Interventions
The study design entails randomizing \~34 Veterans who are undergoing RP for PCa to either usual care or a twice-weekly hybrid (in-person and virtual) yoga program that includes up to 4 weeks of pre-habilitation yoga and 8 weeks of post-RP yoga. Participants will provide data at three time points: baseline/pre-yoga (T1), completion of\~ 4 weeks of pre-RP yoga (T2), and completion of 8 weeks of post-RP yoga (T3). Data collection for the control group will parallel that of the yoga group. Times of data collection are consistent with other yoga trials. Veterans randomized to the intervention will be asked to routinely practice yoga (at least 15 min/day).
Group II: Usual CareActive Control1 Intervention
The control group will consist of "usual care" patients. It is current practice for all patients to: 1) receive a handout that covers Kegel exercises; and, 2) instruction from a nurse who teaches the patient how to perform the exercises. There is no referral to a physical therapist unless progression indicates a need for it.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,658 Previous Clinical Trials
3,361,613 Total Patients Enrolled
4 Trials studying Urinary Incontinence
749 Patients Enrolled for Urinary Incontinence
Abigail Silva, PhD MPH BAPrincipal InvestigatorEdward Hines Jr. VA Hospital, Hines, IL
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I practice yoga twice a week and have a condition like neurogenic bladder, severe heart rhythm problems, psychosis, or cognitive issues.I am scheduled for a major prostate surgery using a robot or traditional method.I cannot do light to moderate exercise.I am 18 years old or older.You are currently struggling with drug or alcohol abuse, except for prescribed painkillers.My prostate cancer diagnosis was confirmed with a biopsy.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Yoga
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger